van Laarhoven HW - Search Results

1

Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach.

Heijmen L, Punt CJ, Ter Voert EG, de Geus-Oei LF, Heerschap A, Bussink J, Sweep CG, Zerbi V, Oyen WJ, Span PN, Boerman O, van Laarhoven HW. Heijmen L, et al. Among authors: van laarhoven hw. Invest New Drugs. 2013 Aug;31(4):881-90. doi: 10.1007/s10637-012-9920-9. Epub 2013 Jan 17. Invest New Drugs. 2013. PMID: 23325291

2

Single-centre experience with tunnelled central venous catheters in 150 cancer patients.

Koolen DA, van Laarhoven HW, Wobbes T, Punt CJ. Koolen DA, et al. Among authors: van laarhoven hw. Neth J Med. 2002 Nov;60(10):397-401. Neth J Med. 2002. PMID: 12607590 Free article.

3

5-FU-induced peripheral neuropathy: a rare complication of a well-known drug.

van Laarhoven HW, Verstappen CC, Beex LV, Kappelle AC, Punt CJ. van Laarhoven HW, et al. Anticancer Res. 2003 Jan-Feb;23(1B):647-8. Anticancer Res. 2003. PMID: 12680161

4

Optimization of localized 19F magnetic resonance spectroscopy for the detection of fluorinated drugs in the human liver.

Klomp DW, Van Laarhoven HW, Kentgens AP, Heerschap A. Klomp DW, et al. Among authors: van laarhoven hw. Magn Reson Med. 2003 Aug;50(2):303-8. doi: 10.1002/mrm.10527. Magn Reson Med. 2003. PMID: 12876706 Free article.

5

Method for quantitation of dynamic MRI contrast agent uptake in colorectal liver metastases.

van Laarhoven HW, Rijpkema M, Punt CJ, Ruers TJ, Hendriks JC, Barentsz JO, Heerschap A. van Laarhoven HW, et al. J Magn Reson Imaging. 2003 Sep;18(3):315-20. doi: 10.1002/jmri.10370. J Magn Reson Imaging. 2003. PMID: 12938126

6

In vivo monitoring of capecitabine metabolism in human liver by 19fluorine magnetic resonance spectroscopy at 1.5 and 3 Tesla field strength.

van Laarhoven HW, Klomp DW, Kamm YJ, Punt CJ, Heerschap A. van Laarhoven HW, et al. Cancer Res. 2003 Nov 15;63(22):7609-12. Cancer Res. 2003. PMID: 14633676

7

Systemic treatment of advanced colorectal carcinoma.

van Laarhoven HW, Punt CJ. van Laarhoven HW, et al. Eur J Gastroenterol Hepatol. 2004 Mar;16(3):283-9. doi: 10.1097/00042737-200403000-00006. Eur J Gastroenterol Hepatol. 2004. PMID: 15195891 Review.

8

Effects of nicotinamide and carbogen in different murine colon carcinomas: immunohistochemical analysis of vascular architecture and microenvironmental parameters.

van Laarhoven HW, Bussink J, Lok J, Punt CJ, Heerschap A, van Der Kogel AJ. van Laarhoven HW, et al. Among authors: van der kogel aj. Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):310-21. doi: 10.1016/j.ijrobp.2004.05.014. Int J Radiat Oncol Biol Phys. 2004. PMID: 15337570

9

Measurements of T1 and T2 relaxation times of colon cancer metastases in rat liver at 7 T.

Gambarota G, Veltien A, van Laarhoven H, Philippens M, Jonker A, Mook OR, Frederiks WM, Heerschap A. Gambarota G, et al. MAGMA. 2004 Dec;17(3-6):281-7. doi: 10.1007/s10334-004-0068-2. Epub 2004 Dec 1. MAGMA. 2004. PMID: 15580375

10

Monitoring fluoropyrimidine metabolism in solid tumors with in vivo (19)F magnetic resonance spectroscopy.

van Laarhoven HW, Punt CJ, Kamm YJ, Heerschap A. van Laarhoven HW, et al. Crit Rev Oncol Hematol. 2005 Dec;56(3):321-43. doi: 10.1016/j.critrevonc.2005.03.009. Epub 2005 Jun 27. Crit Rev Oncol Hematol. 2005. PMID: 15982898 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

595 results

Search Page

Filters